Review article: The aetiology, investigation and management of diarrhoea in the HIV-positive patient

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 6, 2011, Pages 587-603

  Feasey, N A ^a,b   Healey, P ^c   Gordon, M A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIRETROVIRUS AGENT; ATTAPULGITE; BISMUTH SALICYLATE; CIDOFOVIR; CIPROFLOXACIN; CODEINE; COLESTYRAMINE; COTRIMOXAZOLE; CURCUMIN; DIPHENOXYLATE; ETHAMBUTOL; FOSCARNET; GANCICLOVIR; ISONIAZID; KAOLIN PECTIN; LOPERAMIDE; MACROLIDE; MESALAZINE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; PYRAZINAMIDE; RIFAMPICIN; RITONAVIR; TINIDAZOLE; UNINDEXED DRUG; VALGANCICLOVIR; ZIDOVUDINE; ZINC;

ADULT; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CLOSTRIDIUM DIFFICILE; COLITIS; COLONOSCOPY; CRYPTOSPORIDIOSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS COLITIS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDOSCOPY; FECES ANALYSIS; GIARDIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOSPORIASIS; KAPOSI SARCOMA; LUNG TUBERCULOSIS; LYMPHOGRANULOMA VENEREUM; MICROSPORIDIOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PANCREAS DISEASE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; TOXOPLASMA ENCEPHALITIS; TOXOPLASMOSIS; VIRUS ENCEPHALITIS;

ANTI-HIV AGENTS; DIARRHEA; HIV INFECTIONS; HUMANS;

EID: 80052037425     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04781.x     Document Type: Review

References (144)

1. Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985; 2: 849-52. (Pubitemid 16242661)
2. Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 2003; 52 (Suppl. 5): v1-15. (Pubitemid 36760654)
3. Antony MA, Brandt LJ, Klein RS, Bernstein LH,. Infectious diarrhea in patients with AIDS. Dig Dis Sci 1988; 33: 1141-6.
4. Connolly GM, Shanson D, Hawkins DA, Webster JN, Gazzard BG,. Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut 1989; 30: 195-200. (Pubitemid 19058872)
5. Colebunders R, Lusakumuni K, Nelson AM, et al. Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study. Gut 1988; 29: 1687-91.
6. Kelly P, Todd J, Sianongo S, et al. Susceptibility to intestinal infection and diarrhoea in Zambian adults in relation to HIV status and CD4 count. BMC Gastroenterol 2009; 9: 7.
7. Kotler DP,. Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy. J Infect Dis 1999; 179 (Suppl. 3): S454-6. (Pubitemid 29198397)
8. Ullrich R, Zeitz M, Riecken EO,. Enteric immunologic abnormalities in human immunodeficiency virus infection. Semin Liver Dis 1992; 12: 167-74.
9. Clayton F, Snow G, Reka S, Kotler DP,. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin Exp Immunol 1997; 107: 288-92. (Pubitemid 27049254)
10. Monkemuller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM,. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 2005; 50: 230-4. (Pubitemid 40311525)
11. Gordon MA, Banda HT, Gondwe M, et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002; 16: 1633-41. (Pubitemid 34921109)
12. Tee W, Mijch A,. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 1998; 26: 91-6. (Pubitemid 28068160)
13. Sorvillo FJ, Lieb LE, Waterman SH,. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr 1991; 4: 598-602.
14. Nadelman RB, Mathur-Wagh U, Yancovitz SR, Mildvan D,. Salmonella bacteremia associated with the acquired immunodeficiency syndrome (AIDS). Arch Intern Med 1985; 145: 1968-71. (Pubitemid 16198391)
15. Smith PD, Macher AM, Bookman MA, et al. Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 207-9. (Pubitemid 15157173)
16. Gruenewald R, Blum S, Chan J,. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 1994; 18: 358-63. (Pubitemid 24086305)
17. Sanchez TH, Brooks JT, Sullivan PS, et al. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Clin Infect Dis 2005; 41: 1621-7. (Pubitemid 41691601)
18. de la Monte SM, Hutchins GM,. Follicular proctocolitis and neuromatous hyperplasia with lymphogranuloma venereum. Hum Pathol 1985; 16: 1025-32. (Pubitemid 16235401)
19. van Nieuwkoop C, Gooskens J, Smit VT, et al. Lymphogranuloma venereum proctocolitis: mucosal T cell immunity of the rectum associated with chlamydial clearance and clinical recovery. Gut 2007; 56: 1476-7. (Pubitemid 47517851)
20. Burgers WA, Riou C, Mlotshwa M, et al. Association of HIV-specific and total CD8 + T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol 2009; 182: 4751-61.
21. Horsburgh CR Jr,. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1332-8.
22. Wallace JM, Hannah JB,. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest 1988; 93: 926-32.
23. Goodgame RW,. Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med 1996; 124: 429-41. (Pubitemid 26065076)
24. Stark D, Barratt JL, van Hal S, Marriott D, Harkness J, Ellis JT,. Clinical significance of enteric protozoa in the immunosuppressed human population. Clin Microbiol Rev 2009; 22: 634-50.
25. Gertler SL, Pressman J, Price P, Brozinsky S, Miyai K,. Gastrointestinal cytomegalovirus infection in a homosexual man with severe acquired immunodeficiency syndrome. Gastroenterology 1983; 85: 1403-6. (Pubitemid 14232927)
26. Dieterich DT, Rahmin M,. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991; 4 (Suppl. 1): S29-35.
27. Salzberger B, Hartmann P, Hanses F, et al. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection 2005; 33: 345-9. (Pubitemid 41552011)
28. Grohmann GS, Glass RI, Pereira HG, et al. Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. N Engl J Med 1993; 329: 14-20. (Pubitemid 23182873)
29. Veugelers PJ, Kaldor JM, Strathdee SA, et al. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1997; 176: 112-7. (Pubitemid 27272858)
30. Schroder U, Waller V, Kaliebe T, Agathos M, Breit R,. Acute primary stage of HIV infection with documented seroconversion. Hautarzt 1994; 45: 29-33. (Pubitemid 24069317)
31. Uppal B, Kashyap B, Bhalla P,. Enteric pathogens in HIV/AIDS from a tertiary care hospital. Indian J Community Med 2009; 34: 237-42.
32. Vaishnavi C, Kaur S, Prakash S,. Speciation of fecal Candida isolates in antibiotic-associated diarrhea in non-HIV patients. Jpn J Infect Dis 2008; 61: 1-4. (Pubitemid 351338521)
33. Casotti JA, Motta TQ, Ferreira CU Jr, Cerutti C Jr,. Disseminated histoplasmosis in HIV positive patients in Espirito Santo state, Brazil: a clinical-laboratory study of 12 cases (1999-2001). Braz J Infect Dis 2006; 10: 327-30. (Pubitemid 46443733)
34. Connolly GM, Forbes A, Gazzard BG,. Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1. Gut 1990; 31: 886-9. (Pubitemid 20269536)
35. Orenstein JM, Chiang J, Steinberg W, Smith PD, Rotterdam H, Kotler DP,. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: a report of 20 cases. Hum Pathol 1990; 21: 475-81. (Pubitemid 20165140)
36. + T cell depletion and viral replication in SIV infection. Science 1998; 280: 427-31. (Pubitemid 28208163)
37. Sankaran S, George MD, Reay E, et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008; 82: 538-45. (Pubitemid 350309168)
38. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71. (Pubitemid 44924494)
39. + T cell activation in HIV-infected individuals. J Immunol 2010; 185: 5169-79.
40. Brenchley JM, Douek DC,. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1: 23-30.
41. Batman PA, Miller AR, Forster SM, Harris JR, Pinching AJ, Griffin GE,. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol 1989; 42: 275-81. (Pubitemid 19077271)
42. Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR,. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 421-8. (Pubitemid 14018034)
43. Cello JP, Day LW,. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 2009; 136: 1952-65.
44. Bjarnason I, Sharpstone DR, Francis N, et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996; 10: 1385-91. (Pubitemid 26333937)
45. Sharpstone D, Neild P, Crane R, et al. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 1999; 45: 70-6. (Pubitemid 29301848)
46. Keating J, Bjarnason I, Somasundaram S, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995; 37: 623-9.
47. Kapembwa MS, Fleming SC, Sewankambo N, et al. Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Lond) 1991; 81: 327-34.
48. Knox TA, Spiegelman D, Skinner SC, Gorbach S,. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000; 95: 3482-9.
49. Dandekar S, George MD, Baumler AJ,. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010; 5: 173-8.
50. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14: 421-8. (Pubitemid 351499394)
51. Ruttimann S, Hilti P, Spinas GA, Dubach UC,. High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Arch Intern Med 1991; 151: 2441-3.
52. Johnson L, Jarvis JN, Wilkins EG, Hay PE,. Thalidomide treatment for refractory HIV-associated colitis: a case series. Clin Infect Dis 2008; 47: 133-6. (Pubitemid 351920601)
53. Martin SI, Mueller PS,. 39-year-old man with human immunodeficiency virus infection and abdominal pain. Mayo Clin Proc 2003; 78: 1285-8. (Pubitemid 37193519)
54. Dinh MH, Matkowskyj KA, Stosor V,. Colorectal lymphoma in the setting of HIV: case report and review of the literature. AIDS Patient Care STDS 2009; 23: 227-30.
55. Siani LM, Siani A, Ricci V, D'Elia M, Masoni T, Uggeri G,. Burkitt's lymphoma of the caecum in a patient with AIDS: clinical case and review of the literature. Minerva Chir 2009; 64: 229-33.
56. Cappell MS, Botros N,. Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study including 763 HIV-seropositive patients. Am J Gastroenterol 1994; 89: 545-9. (Pubitemid 24106221)
57. Grogg KL, Miller RF, Dogan A,. HIV infection and lymphoma. J Clin Pathol 2007; 60: 1365-72. (Pubitemid 350247252)
58. Engels EA,. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS 2009; 23: 875-85.
59. Kahl P, Buettner R, Friedrichs N, Merkelbach-Bruse S, Wenzel J, Carl Heukamp L,. Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature. Pathol Res Pract 2007; 203: 227-31. (Pubitemid 46605955)
60. Lee HF, Lu CL, Chang FY,. A man with loose stool and periumbilical pain. Gastroenterology 2010; 139: 734.
61. Dassopoulos T, Ehrenpreis ED,. Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med 1999; 107: 78-84. (Pubitemid 29328285)
62. Price DA, Schmid ML, Ong EL, Adjukeiwicz KM, Peaston B, Snow MH,. Pancreatic exocrine insufficiency in HIV-positive patients. HIV Med 2005; 6: 33-6. (Pubitemid 40268114)
63. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185-91. (Pubitemid 17114872)
64. Battegay M, Elzi L,. Morbidity and mortality in HIV-infected individuals-a shift towards comorbidities. Swiss Med Wkly 2009; 139: 564-70.
65. O'Brien ME, Clark RA, Besch CL, Myers L, Kissinger P,. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr 2003; 34: 407-14. (Pubitemid 37444469)
66. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333: 1534-9.
67. Kempf DJ, Marsh KC, Kumar G, et al. Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob Agents Chemother 1997; 41: 654-60. (Pubitemid 27098420)
68. Hill A, van der Lugt J, Sawyer W, Boffito M,. How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials. AIDS 2009; 23: 2237-45.
69. Health Protection Agency. Investigation of faecal specimens for bacterial pathogens. National Standard Method. BSOP 2008; 30: 1-34. Available at:.
70. Health Protection Agency. Investigation of specimens other than blood for parasites. National Standard Method. BSOP 2008; 31: 1-45. Available at:.
71. Ghosh K, Weiss LM,. Molecular diagnostic tests for microsporidia. Interdiscip Perspect Infect Dis 2009; 2009: 926521.
72. Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS,. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N Engl J Med 1992; 326: 161-6.
73. Drew WL,. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 2007; 20: 408-11. (Pubitemid 47026239)
74. Ganzenmueller T, Henke-Gendo C, Schlue J, Wedemeyer J, Huebner S, Heim A,. Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease. J Clin Virol 2009; 46: 254-8.
75. Connolly GM, Forbes A, Gleeson JA, Gazzard BG,. The value of barium enema and colonoscopy in patients infected with HIV. AIDS 1990; 4: 687-9. (Pubitemid 20242058)
76. Kearney DJ, Steuerwald M, Koch J, Cello JP,. A prospective study of endoscopy in HIV-associated diarrhea. Am J Gastroenterol 1999; 94: 596-602. (Pubitemid 29124852)
77. Wilcox CM, Chalasani N, Lazenby A, Schwartz DA,. Cytomegalovirus colitis in acquired immunodeficiency syndrome: a clinical and endoscopic study. Gastrointest Endosc 1998; 48: 39-43. (Pubitemid 28337426)
78. Bini EJ, Weinshel EH,. Endoscopic evaluation of chronic human immunodeficiency virus-related diarrhea: is colonoscopy superior to flexible sigmoidoscopy? Am J Gastroenterol 1998; 93: 56-60. (Pubitemid 29065514)
79. Nkuize M, De Wit S, Muls V, Arvanitakis M, Buset M,. Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy. HIV Med 2010; 11: 412-7.
80. Knollmann FD, Grunewald T, Adler A, et al. Intestinal disease in acquired immunodeficiency: evaluation by CT. Eur Radiol 1997; 7: 1419-29. (Pubitemid 127538378)
81. Pantongrag-Brown L, Nelson AM, Brown AE, Buetow PC, Buck JL,. Gastrointestinal manifestations of acquired immunodeficiency syndrome: radiologic-pathologic correlation. Radiographics 1995; 15: 1155-78.
82. Koh DM LB, Padley SPG,. Abdominal CT in patients with AIDS. Imaging 2002; 3: 24-34. (Pubitemid 351649423)
83. Tshibwabwa ET, Mwaba P, Bogle-Taylor J, Zumla A,. Four-year study of abdominal ultrasound in 900 Central African adults with AIDS referred for diagnostic imaging. Abdom Imaging 2000; 25: 290-6. (Pubitemid 30304990)
84. Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR,. Tuberculosis: a radiologic review. Radiographics 2007; 27: 1255-73.
85. Pantongrag-Brown L, Krebs TL, Daly BD, et al. Frequency of abdominal CT findings in AIDS patients with M. avium complex bacteraemia. Clin Radiol 1998; 53: 816-9. (Pubitemid 28517516)
86. Reeders JWAJ, Rosenbusch G,. Clincial radiology and endoscopy of the colon. Stuttgart: Thieme, 1994.
87. Thuluvath PJ, Connolly GM, Forbes A, Gazzard BG,. Abdominal pain in HIV infection. Q J Med 1991; 78: 275-85.
88. Balthazar EJ, Megibow AJ, Barry M, Opulencia JF,. Histoplasmosis of the colon in patients with AIDS: imaging findings in four cases. AJR Am J Roentgenol 1993; 161: 585-7. (Pubitemid 23268685)
89. Hoeffel C, Crema MD, Belkacem A, et al. Multi-detector row CT: spectrum of diseases involving the ileocecal area. Radiographics 2006; 26: 1373-90. (Pubitemid 44518769)
90. Till M, Lee N, Soper WD, Murphy RL,. Typhlitis in patients with HIV-1 infection. Ann Intern Med 1992; 1: 998-1000.
91. Restrepo CS, Martinez S, Lemos JA, et al. Imaging manifestations of Kaposi sarcoma. Radiographics 2006; 26: 1169-85. (Pubitemid 44180888)
92. Radin DR, Esplin JA, Levine AM, Ralls PW,. AIDS-related non-Hodgkin's lymphoma: abdominal CT findings in 112 patients. AJR Am J Roentgenol 1993; 160: 1133-9. (Pubitemid 23141268)
93. Ghai S, Pattison J, O'Malley ME, Khalili K, Stephens M,. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics 2007; 27: 1371-88.
94. Balthazar EJ, Noordhoorn M, Megibow AJ, Gordon RB,. CT of small-bowel lymphoma in immunocompetent patients and patients with AIDS: comparison of findings. AJR Am J Roentgenol 1997; 168: 675-80. (Pubitemid 27089929)
95. Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, Raja A,. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS ONE 2009; 4: e5718.
96. Liao CH, Chou CH, Lai CC, et al. Diagnostic performance of an enzyme-linked immunospot assay for interferon-gamma in extrapulmonary tuberculosis varies between different sites of disease. J Infect 2009; 59: 402-8.
97. Excellence NIfC. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control 2011 (CG117).
98. Kasperbauer SH, Daley CL,. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med 2008; 29: 569-76.
99. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
100. Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM,. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis 2010; 4: e682.
101. Rossignol JF, Ayoub A, Ayers MS,. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001; 184: 381-4. (Pubitemid 32662190)
102. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR,. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 2007; 63: 387-93. (Pubitemid 46426641)
103. Miao YM, Awad-El-Kariem FM, Franzen C, et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 124-9.
104. Carr A, Marriott D, Field A, Vasak E, Cooper DA,. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351: 256-61. (Pubitemid 28043951)
105. Sungkanuparph S, Chakriyanuyok T, Butthum B,. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome. J Infect 2008; 56: 40-3. (Pubitemid 350253654)
106. Verdier RI, Fitzgerald DW, Johnson WD Jr, Pape JW,. Trimethoprim- sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 2000; 132: 885-8. (Pubitemid 30346851)
107. Molina JM, Chastang C, Goguel J, et al. Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial. J Infect Dis 1998; 177: 1373-7. (Pubitemid 28194281)
108. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H,. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 4: 1-207.
109. Mermin J, Lule J, Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364: 1428-34. (Pubitemid 39370718)
110. Gazzard BG, Anderson J, Babiker A, et al. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008; 9: 563-608.
111. Jain V, Deeks SG,. When to start antiretroviral therapy. Curr HIV/AIDS Rep 2010; 7: 60-8.
112. Kotler DP, Shimada T, Snow G, et al. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS 1998; 12: 597-604. (Pubitemid 28162098)
113. Monkemuller KE, Call SA, Lazenby AJ, Wilcox CM,. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000; 95: 457-62. (Pubitemid 30106176)
114. Hung CC, Hung MN, Hsueh PR, et al. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Clin Infect Dis 2007; 45: e60-7.
115. Mehandru S, Poles MA, Tenner-Racz K, et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 2006; 3: e484.
116. Guadalupe M, Sankaran S, George MD, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006; 80: 8236-47. (Pubitemid 44182323)
117. Estes J, Baker JV, Brenchley JM, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008; 198: 456-64.
118. Epple HJ, Schneider T, Troeger H, et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009; 58: 220-7.
119. Nwachukwu CE, Okebe JU,. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev 2008; 4: CD005644.
120. Steuerwald M, Bucher HC, Muller-Brand J, Gotze M, Roser HW, Gyr K,. HIV-enteropathy and bile acid malabsorption: response to cholestyramine. Am J Gastroenterol 1995; 90: 2051-3.
121. Carcamo C, Hooton T, Weiss NS, et al. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection. J Acquir Immune Defic Syndr 2006; 43: 197-201. (Pubitemid 44454814)
122. Rodriguez-Torres M, Rodriguez-Orengo JF, Rios-Bedoya CF, Fernandez-Carbia A, Salgado-Mercado R, Marxuach-Cuetara AM,. Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients. Dig Dis Sci 2006; 51: 161-7. (Pubitemid 43106355)
123. Conteas CN, Panossian AM, Tran TT, Singh HM,. Treatment of HIV-associated diarrhea with curcumin. Dig Dis Sci 2009; 54: 2188-91.
124. Irlam JH, Visser ME, Rollins N, Siegfried N, Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2005; 4: CD003650.
125. Kelly P, Katubulushi M, Todd J, et al. Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial. Am J Clin Nutr 2008; 88: 1010-7.
126. Kelly P, Shawa T, Mwanamakondo S, et al. Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial. BMC Gastroenterol 2010; 10: 72.
127. Cello JP, Grendell JH, Basuk P, et al. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Ann Intern Med 1991; 115: 705-10.
128. Simon DM, Cello JP, Valenzuela J, et al. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea. Gastroenterology 1995; 108: 1753-60.
129. Garcia Compean D, Ramos Jimenez J, Guzman de la Garza F, et al. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial. AIDS 1994; 8: 1563-7. (Pubitemid 24335093)
130. Urbach DR, Rotstein OD,. Typhlitis. Can J Surg 1999; 42: 415-9.
131. Saksirisampant W, Prownebon J, Saksirisampant P, Mungthin M, Siripatanapipong S, Leelayoova S,. Intestinal parasitic infections: prevalences in HIV/AIDS patients in a Thai AIDS-care centre. Ann Trop Med Parasitol 2009; 103: 573-81.
132. Goncalves AC, Gabbay YB, Mascarenhas JD, et al. Calicivirus and Giardia lamblia are associated with diarrhea in human immunodeficiency virus-seropositive patients from southeast Brazil. Am J Trop Med Hyg 2009; 81: 463-6.
133. Dillingham RA, Pinkerton R, Leger P, et al. High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study. Am J Trop Med Hyg 2009; 80: 1060-4.
134. Chacin-Bonilla L, Panunzio AP, Monsalve-Castillo FM, Parra-Cepeda IE, Martinez R,. Microsporidiosis in Venezuela: prevalence of intestinal microsporidiosis and its contribution to diarrhea in a group of human immunodeficiency virus-infected patients from Zulia State. Am J Trop Med Hyg 2006; 74: 482-6. (Pubitemid 46774373)
135. Chacin-Bonilla L, Estevez J, Monsalve F, Quijada L,. Cyclospora cayetanensis infections among diarrheal patients from Venezuela. Am J Trop Med Hyg 2001; 65: 351-4. (Pubitemid 33022025)
136. Blanshard C, Francis N, Gazzard BG,. Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut 1996; 39: 824-32. (Pubitemid 27049085)
137. Blanshard C, Gazzard BG,. Natural history and prognosis of diarrhoea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS). Gut 1995; 36: 283-6.
138. Sorvillo FJ, Lieb LE, Seidel J, Kerndt P, Turner J, Ash LR,. Epidemiology of isosporiasis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1995; 53: 656-9. (Pubitemid 26036357)
139. Sorvillo FJ, Lieb LE, Kerndt PR, Ash LR,. Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1994; 51: 326-31. (Pubitemid 24300825)
140. Chacin-Bonilla L, Guanipa N, Cano G, Raleigh X, Quijada L,. Cryptosporidiosis among patients with acquired immunodeficiency syndrome in Zulia State, Venezuela. Am J Trop Med Hyg 1992; 47: 582-6.
141. Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ, et al. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 1991; 337: 895-8.
142. Janoff EN, Orenstein JM, Manischewitz JF, Smith PD,. Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology 1991; 100: 976-9.
143. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG,. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 1991; 114: 366-72.
144. Rene E, Marche C, Chevalier T, et al. Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome. Dig Dis Sci 1988; 33: 741-50.